On October 6, 2009
Sanofi’s Multaq Unlikely to Be a Blockbuster, Says Analyst
Before Sanofi-Aventis launched its heart drug Multaq, some analysts estimated revenues would top €3 billion. But 10 weeks into the launch, Multaq looks like a much more modest affair, according to a note to investors from Jefferies International.
0 Comments